Hepatitis C Virus Infection Is Not An Independent Risk Factor For Obstructive Lung Disease

References

• Snyder LD, Eisner MD. Obstructive lung disease among the urban homeless. Chest 2004; 125(5):1719–1725. Epub 2004/05/12.
   PubMed Web of Science ®Google Scholar
• Diaz PT, King ER, Wewers MD, Gadek JE, Neal D, Drake J, HIV infection increases susceptibility to smoking-induced emphysema. Chest 2000; 117(5 Suppl 1):285S. Epub 2000/06/10.
   PubMed Web of Science ®Google Scholar
• Drummond MB, Kirk GD, Astemborski J, Marshall MM, Mehta SH, McDyer JF, Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax 2012; 67(4):309–314. Epub 2011/11/18.
   PubMed Web of Science ®Google Scholar
• Hayashi S, Hogg JC. Adenovirus infections and lung disease. Curr Opin Pharmacol 2007; 7(3):237–243. Epub 2007/04/21.
   PubMed Web of Science ®Google Scholar
• Kang MJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, Enelow R, Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest 2008; 118(8):2771–2784. Epub 2008/07/26.
   PubMed Web of Science ®Google Scholar
• Meshi B, Vitalis TZ, Ionescu D, Elliott WM, Liu C, Wang XD, Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol 2002; 26(1):52–57. Epub 2001/12/26.
   PubMed Web of Science ®Google Scholar
• Moorman J, Saad M, Kosseifi S, Krishnaswamy G. Hepatitis C virus and the lung: implications for therapy. Chest. 2005; 128(4):2882–2892. Epub 2005/10/21.
   PubMed Web of Science ®Google Scholar
• Idilman R, Cetinkaya H, Savas I, Aslan N, Sak SD, Bastemir M, Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C. J Med Virol. 2002; 66(1):34–39. Epub 2001/12/19.
   PubMed Web of Science ®Google Scholar
• Kubo K, Yamaguchi S, Fujimoto K, Hanaoka M, Hayasaka M, Honda T, Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection. Thorax 1996; 51(3):312–314. Epub 1996/03/01.
   PubMed Web of Science ®Google Scholar
• Yamaguchi S, Kubo K, Fujimoto K, Honda T, Sekiguchi M, Sodeyama T. Analysis of bronchoalveolar lavage fluid in patients with chronic hepatitis C before and after treatment with interferon alpha. Thorax 1997; 52(1):33–37. Epub 1997/01/01.
   PubMed Web of Science ®Google Scholar
• Erol Sea. Hepatitis C infection and COPD. Hepatitis Month 2009; 9(1):39–44.
   Web of Science ®Google Scholar
• Kanazawa H, Hirata K, Yoshikawa J. Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patients. Chest 2003; 123(2):596–599. Epub 2003/02/11.
   PubMed Web of Science ®Google Scholar
• Silva DR, Stifft J, Cheinquer H, Knorst MM. Prevalence of hepatitis C virus infection in patients with COPD. Epidemiol Infect 2010; 138(2):167–173. Epub 2009/07/01.
   PubMed Web of Science ®Google Scholar
• Louie KS, St Laurent S, Forssen UM, Mundy LM, Pimenta JM. The high comorbidity burden of the hepatitis C virus infected population in the United States. BMC Infect Dis 2012; 12:86. Epub 2012/04/13.
   PubMed Web of Science ®Google Scholar
• Kanazawa H, Yoshikawa J. Accelerated decline in lung function and impaired reversibility with salbutamol in asthmatic patients with chronic hepatitis C virus infection: a 6-year follow-up study. Am J Med 2004; 116(11):749–752. Epub 2004/05/18.
   PubMed Web of Science ®Google Scholar
• Gingo MG, MP; Lucht, L; Kessinger, C; Rissler, B; Weinman, R; Slivka, WA, McMahon, D; Sciurba, FC; Morris, A. Pulmonary function in human immunodeficiency virus infected individuals [abstract]. Am J Respir Crit Care Med 2010; 181(A5201).
   Google Scholar
• Meffre C, Le Strat Y, Delarocque-Astagneau E, Dubois F, Antona D, Lemasson JM, Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol 2010; 82(4):546–555. Epub 2010/02/19.
   Google Scholar
• Esteban JI, Esteban R, Viladomiu L, Lopez-Talavera JC, Gonzalez A, Hernandez JM, Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2(8658):294–297. Epub 1989/08/05.
   PubMed Web of Science ®Google Scholar
• Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182(5):693–718. Epub 2010/08/31.
   PubMed Web of Science ®Google Scholar
• Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet 2011; 378(9795):991–6. Epub 2011/09/13.
   Google Scholar
• Morris A, Sciurba FC, Lebedeva IP, Githaiga A, Elliott WM, Hogg JC, Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med 2004; 170(4):408–413. Epub 2004/05/01.
   Google Scholar
• Yamini D, Basseri B, Chee GM, Arakelyan A, Enayati P, Tran TT, Tobacco and other factors have a negative impact on quality of life in hepatitis C patients. J Viral Hepat 2011; 18(10):714–720. Epub 2010/08/21.
   PubMed Web of Science ®Google Scholar
• Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, Celentano DD, The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991; 109:75–100. Epub 1991/01/01.
   PubMedGoogle Scholar
• Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284(4):450–456. Epub 2000/07/25.
   PubMed Web of Science ®Google Scholar
• Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, Vlahov D, Changes in blood-borne infection risk among injection drug users. J Infect Dis 2011; 203(5):587–594. Epub 2011/02/02.
   PubMed Web of Science ®Google Scholar
• Kirk GD, Astemborski J, Mehta SH, Spoler C, Fisher C, Allen D, Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis 2009; 48(7):963–972. Epub 2009/02/25.
   PubMed Web of Science ®Google Scholar
• Mehta SR, Kosakovsky Pond SL, Young JA, Richman D, Little S, Smith DM. Associations between phylogenetic clustering and HLA profile among HIV-infected individuals in San Diego, California. J Infect Dis 2012; 205(10):1529–1533. Epub 2012/03/27.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Standardisation of spirometry. Eur Respir J 2005; 26(2):319–338. Epub 2005/08/02.
   PubMed Web of Science ®Google Scholar
• From the Global Strategy for the Diagnosis Management and Prevention of COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available from: http://www.goldcopd.org/ [database on the Internet].
   Google Scholar
• Mehta SH, Genberg BL, Astemborski J, Kavasery R, Kirk GD, Vlahov D, Limited uptake of hepatitis C treatment among injection drug users. J Commun Health 2008; 33(3):126–133. Epub 2008/01/01.
   PubMed Web of Science ®Google Scholar
• Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006; 130(5):1326–1333. Epub 2006/11/14.
   PubMed Web of Science ®Google Scholar